Sign In / Join

favorite Donate

close

person Sign In / Create Account

HealthTree News

HealthTree News is a place to learn all about your disease in easy-to-understand language. The site features news articles, patient stories, basics articles, and clinical trial updates with new content every week.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

HealthTree Foundation Founder Jenny Ahlstrom Featured on The Pulse Podcast

Feb. 21, 2025

HealthTree Foundation Founder Jenny Ahlstrom Featured on The Pulse Podcast

$Findings from an International Phase 3 Trial: Uproleselan for Relapsed/Refractory AML$

Feb. 17, 2025

Findings from an International Phase 3 Trial: Uproleselan for Relapsed/Refractory AML

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)

Feb. 14, 2025

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)

Midostaurin for FLT3-Mutated AML, 10 Years Later

Feb. 13, 2025

Midostaurin for FLT3-Mutated AML, 10 Years Later

$Olutasidenib Study Results for Relapsed/Refractory AML$

Feb. 11, 2025

Olutasidenib Study Results for Relapsed/Refractory AML

Study Highlights The Need for Risk Models in AML for Black Patients

Feb. 06, 2025

Study Highlights The Need for Risk Models in AML for Black Patients

HealthTree Foundation Honors Leading Blood Cancer Researchers at ASH 2024 Awards Reception

Feb. 04, 2025

HealthTree Foundation Honors Leading Blood Cancer Researchers at ASH 2024 Awards Reception

FDA Approval of Treosulfan for AML and MDS

Feb. 02, 2025

FDA Approval of Treosulfan for AML and MDS

An Opportunity to Take Action: Regional Cure Teams

Jan. 31, 2025

An Opportunity to Take Action: Regional Cure Teams

Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients

Jan. 31, 2025

Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients

Why Should You Quit Smoking If You Have MDS or AML?

Jan. 30, 2025

Why Should You Quit Smoking If You Have MDS or AML?

Astonishing Reversal on Cancer Research Funding Freeze

Jan. 28, 2025

Astonishing Reversal on Cancer Research Funding Freeze

Recent Articles

The Latest in Pediatric AML Research and Innovations image

The Latest in Pediatric AML Research and Innovations

January 16, 2025

Explore breakthroughs in pediatric AML, from cardiac care to therapies, highlighted at the ASH annual conference.

Changes in ACA and Medicaid: What You Need to Know and How to Prepare image

Changes in ACA and Medicaid: What You Need to Know and How to Prepare

January 14, 2025

Learn the potential changes to the Affordable Care Act and Medicaid insurance and how you can act now to ensure full coverage and savings in the new year.

Breaking Barriers in AML Care: Addressing Survival Disparities in Young Adults image

Breaking Barriers in AML Care: Addressing Survival Disparities in Young Adults

January 09, 2025

What are current survival rates for AYAs diagnosed with AML? What disparities exist in this population and how can they be solved?

Treatment Advances

Olutasidenib Study Results for Relapsed/Refractory AML image

Olutasidenib Study Results for Relapsed/Refractory AML

FDA Approval of Treosulfan for AML and MDS image

FDA Approval of Treosulfan for AML and MDS

The Latest in Pediatric AML Research and Innovations image

The Latest in Pediatric AML Research and Innovations

Updates in Treatment Options for TP53-Mutant AML and MDS image

Updates in Treatment Options for TP53-Mutant AML and MDS

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib image

FDA Approves New Treatment for R/R Acute Leukemia with KMT2A Translocation: Revumenib

AML: Donor Age, Not Just a Number image

AML: Donor Age, Not Just a Number

Load More

Core Education

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML) image

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)

What are FLT3 Inhibitors, and How are They Used in AML? image

What are FLT3 Inhibitors, and How are They Used in AML?

What is Pancytopenia? Symptoms, Causes, & Treatments image

What is Pancytopenia? Symptoms, Causes, & Treatments

What Are The AML Types, and How Are They Classified? image

What Are The AML Types, and How Are They Classified?

Does AML Go to the Brain? image

Does AML Go to the Brain?

What is Relapsed & Refractory AML? image

What is Relapsed & Refractory AML?

Load More

Trending Articles

FDA Approval of Treosulfan for AML and MDS

Olutasidenib Study Results for Relapsed/Refractory AML

Understanding the Timing of Treatment in Acute Myeloid Leukemia (AML)

Former NHL Player Kelly Chase Shares an Update on His AML Treatment

Venetoclax Plus 7+3 Chemotherapy: A Promising Induction Therapy for Newly Diagnosed AML

Upcoming Events

Hospice Care Unveiled: Understanding What It Is (and Isn’t) for AML Patients

Hospice Care Unveiled: Understanding What It Is (and Isn’t) for AML Patients

Feb 25 / 13:00 EST

Fuel Your Health: Nutrition Strategies & Anemia Insights for MDS Patients

Fuel Your Health: Nutrition Strategies & Anemia Insights for MDS Patients

Feb 26 / 16:00 EST

Patient Stories

articles for Patient Stories

Former NHL Player Kelly Chase Shares an Update on His AML Treatment James' Journey with AML: A Story of Resilience and Acceptance Meet AML Coach, Steve Hodges

HealthTree Research

articles for HealthTree Research

Revolutionizing Blood Cancer Care: HealthTree Foundation's Commitment to Innovation Share HealthTree Cure Hub to Accelerate AML Research Participate in AML Research: Transportation Survey

Conferences

articles for Conferences

Understanding Barriers to CAR T-Cell Therapy for Blood Cancer Patients Why Should You Quit Smoking If You Have MDS or AML? Breaking Barriers in AML Care: Addressing Survival Disparities in Young Adults

Clinical Trials

articles for Clinical Trials

Findings from an International Phase 3 Trial: Uproleselan for Relapsed/Refractory AML Recruiting Trials for New Therapy Regimen for AML Patients RVU120: A New Treatment in Clinical Trials for AML, MDS, and Myelofibrosis

HealthTree Press

articles for HealthTree Press

HealthTree Foundation Founder Jenny Ahlstrom Featured on The Pulse Podcast HealthTree Foundation Honors Leading Blood Cancer Researchers at ASH 2024 Awards Reception HealthTree Foundation Featured on Fox News

HealthTree Programs

articles for HealthTree Programs

An Opportunity to Take Action: Regional Cure Teams The Future of Blood Cancer: Advances in Detection, Treatment, and Research AML and Fertility: Unlocking Knowledge with HealthTree University for AML

All the HealthTree resources anywhere, anytime.

Download our App

Download iOS App

Download Android App

iphone app mockup

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Kura Oncology

Follow Us

Download our App

Download iOS App

Download Android App

Charity Navigator

HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2025 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811